Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
TRNAU1AP	54952	broad.mit.edu	37	1	28907141	28907141	+	IGR	SNP	C	C	T			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr1:28907141C>T	ENST00000373830.3	+	0	1793				SNHG12_ENST00000475441.1_RNA|SNORD99_ENST00000408612.1_RNA|SNHG12_ENST00000384342.1_RNA|SNHG12_ENST00000384584.1_RNA|SNHG12_ENST00000483436.1_RNA|SNHG12_ENST00000531126.1_RNA|SNHG12_ENST00000488745.1_RNA|SNHG12_ENST00000384581.1_RNA	NM_017846.4	NP_060316.1	Q9NX07	TSAP1_HUMAN	tRNA selenocysteine 1 associated protein 1	NA		NA		NA	selenocysteine incorporation	cytoplasm|nucleus	nucleotide binding|RNA binding		NA	breast(1)|endometrium(2)|large_intestine(2)|ovary(1)|pancreas(1)|skin(1)	8						CACCTTCTGTCATCTTAAGAG	0.428		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA			NA	NA			NA															NA		NA	NA	NA	SO:0001628	intergenic_variant			ENSG00000180098	HGNC:30813	NM_017846	Approved	uc001bqi.3	NA	Q86SU7	ENST00000373830.3	37	CCDS324.1												NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		TRNAU1AP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000010346.1	40.04593	KEEP		+	40.05355	0.482759	14	15	---	---	---	---	1	0.998149	5	11	0	30	14	15	0	30	2	0	0	0	0	0	0	14	15	0	30	2	TP
RNPEP	6051	broad.mit.edu	37	1	201966632	201966632	+	Missense_Mutation	SNP	A	A	T	rs114130028		GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr1:201966632A>T	ENST00000295640.4	+	5	1083	c.1040A>T	c.(1039-1041)aAt>aTt	p.N347I	RP11-465N4.4_ENST00000415582.1_RNA|RP11-465N4.4_ENST00000419190.1_RNA|RNPEP_ENST00000471105.1_3'UTR|RNPEP_ENST00000367286.3_Missense_Mutation_p.N308I	NM_020216.3	NP_064601.3	Q9H4A4	AMPB_HUMAN	arginyl aminopeptidase (aminopeptidase B)	347		NA		NA	leukotriene biosynthetic process		epoxide hydrolase activity|zinc ion binding		NA	breast(1)|endometrium(4)|large_intestine(4)|lung(6)|skin(2)|stomach(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	21				KIRC - Kidney renal clear cell carcinoma(1967;3.23e-08)|Colorectal(1306;0.005)		TTCTGGCTCAATGAAGGTTTC	0.542		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(19;39 479 7473 13131 19462)							NA				0							NA						104	90	95			NA	NA	1		NA															201966632		2203	4300	6503	SO:0001583	missense			ENSG00000176393	HGNC:10078	NM_020216	Approved	uc001gxd.3	NA	Q9BVM9|Q9H1D4|Q9NPT7	ENST00000295640.4	37	CCDS1418.1	.	.	.	.	.	.	.	.	.	.	A	19.9	3.912863	0.72983	.	.	ENSG00000176393	ENST00000295640;ENST00000367286;ENST00000447312;ENST00000449524	T;T;T;T	0.05580	3.42;3.42;3.42;3.42	5.1	5.1	0.69264	Peptidase M1, membrane alanine aminopeptidase, N-terminal (2);	0.000000	0.85682	D	0.000000	T	0.35189	0.0923	H	0.94925	3.6	0.54753	D	0.999982	D;D	0.89917	1.0;0.999	D;D	0.85130	0.997;0.995	T	0.50303	-0.8844	10	0.87932	D	0	-28.5664	13.8782	0.63667	1.0:0.0:0.0:0.0	.	355;347	Q7RU04;Q9H4A4	.;AMPB_HUMAN	I	347;308;216;93	ENSP00000295640:N347I;ENSP00000356255:N308I;ENSP00000389602:N216I;ENSP00000407614:N93I	ENSP00000295640:N347I	N	+	2	0	RNPEP	200233255	1	0.71417	0.994	0.49952	0.996	0.88848	5.699	0.6831	1.914	0.55421	0.523	0.50628	AAT	RNPEP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000087345.1	185.29879	KEEP		+	186.708269	0.395973	59	90	---	---	---	---	1	0.9999991	15	23	0	184	60	97	0	184	2	0	0	0	0	0	0	60	97	0	184	2	TP
RPS6KC1	26750	broad.mit.edu	37	1	213414537	213414537	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr1:213414537T>C	ENST00000366960.3	+	11	1868	c.1718T>C	c.(1717-1719)tTc>tCc	p.F573S	RPS6KC1_ENST00000543470.1_Missense_Mutation_p.F361S|RPS6KC1_ENST00000366959.3_Missense_Mutation_p.F561S|RPS6KC1_ENST00000543354.1_Missense_Mutation_p.F276S|RPS6KC1_ENST00000490299.1_3'UTR	NM_012424.3	NP_036556.2	Q96S38	KS6C1_HUMAN	ribosomal protein S6 kinase, 52kDa, polypeptide 1	573		NA		NA	cell communication|signal transduction	early endosome|membrane	ATP binding|phosphatidylinositol binding|protein binding|protein serine/threonine kinase activity		NA	breast(1)|endometrium(6)|kidney(4)|large_intestine(8)|liver(2)|lung(15)|ovary(3)|prostate(1)|urinary_tract(3)	43				OV - Ovarian serous cystadenocarcinoma(81;0.00705)|all cancers(67;0.016)|GBM - Glioblastoma multiforme(131;0.0663)|Epithelial(68;0.145)		CTGAAGTTCTTCCCCAACGAT	0.458		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						53	52	52			NA	NA	1		NA															213414537		2203	4300	6503	SO:0001583	missense			ENSG00000136643	HGNC:10439	NM_012424	Approved	uc010ptr.2	NA	B3KVM4|D3DTA4|Q8TDD3|Q9NSF4|Q9UL66	ENST00000366960.3	37	CCDS1513.1	.	.	.	.	.	.	.	.	.	.	T	13.3	2.19726	0.38806	.	.	ENSG00000136643	ENST00000543470;ENST00000366960;ENST00000366959;ENST00000543354	T;T;T;T	0.54675	0.97;1.07;1.09;0.56	5.03	3.87	0.44632	.	0.179480	0.49305	D	0.000143	T	0.65365	0.2684	M	0.66939	2.045	0.36266	D	0.854857	D;D;D	0.69078	0.991;0.997;0.997	P;D;D	0.64042	0.886;0.921;0.921	T	0.70389	-0.4885	10	0.40728	T	0.16	-27.833	11.0345	0.47793	0.1393:0.0:0.0:0.8607	.	361;573;561	F5H7T0;Q96S38;B1APS8	.;KS6C1_HUMAN;.	S	361;573;561;276	ENSP00000442306:F361S;ENSP00000355927:F573S;ENSP00000355926:F561S;ENSP00000439282:F276S	ENSP00000355926:F561S	F	+	2	0	RPS6KC1	211481160	0.999	0.42202	0.017	0.16124	0.682	0.39822	2.409	0.44583	0.729	0.32403	0.377	0.2321	TTC	RPS6KC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000089690.3	146.232233	KEEP		+	146.842813	0.419048	44	61	---	---	---	---	1	0.9989107	9	10	0	166	46	65	0	166	2	0	0	0	0	0	0	46	65	0	166	2	TP
SPTBN1	0	broad.mit.edu	37	2	54856159	54856159	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr2:54856159C>T	ENST00000333896.5	+	13	2234	c.1849C>T	c.(1849-1851)Cgc>Tgc	p.R617C	SPTBN1_ENST00000356805.4_Missense_Mutation_p.R630C	NM_178313.2	NP_842565.2	Q01082	SPTB2_HUMAN	spectrin, beta, non-erythrocytic 1	630		NA		NA	actin filament capping|axon guidance	cytosol|nucleolus|plasma membrane|sarcomere|spectrin	actin binding|calmodulin binding|protein binding|structural constituent of cytoskeleton		NA	NS(1)|breast(8)|central_nervous_system(2)|endometrium(10)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(11)|lung(27)|ovary(4)|prostate(2)|skin(5)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(1)	82			Lung(47;0.24)			GGCGGCTGAGCGCAGGGCCCG	0.582		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						61	71	67			NA	NA	2		NA															54856159		2202	4300	6502	SO:0001583	missense			ENSG00000115306	HGNC:11275		Approved	uc002rxu.3	NA	B2RP63|O60837|Q16057|Q53R99|Q59ER3|Q8IX99	ENST00000333896.5	37	CCDS33199.1	.	.	.	.	.	.	.	.	.	.	C	24.3	4.511663	0.85389	.	.	ENSG00000115306	ENST00000356805;ENST00000389980;ENST00000333896	T;T;T	0.63096	-0.02;-0.02;-0.02	5.61	5.61	0.85477	.	0.000000	0.85682	D	0.000000	D	0.83862	0.5346	M	0.93720	3.45	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	1.0;1.0	D	0.87575	0.2480	10	0.87932	D	0	.	14.4694	0.67506	0.1469:0.853:0.0:0.0	.	617;630	Q01082-3;Q01082	.;SPTB2_HUMAN	C	630;630;617	ENSP00000349259:R630C;ENSP00000374630:R630C;ENSP00000334156:R617C	ENSP00000334156:R617C	R	+	1	0	SPTBN1	54709663	1	0.71417	1	0.80357	0.998	0.95712	5.877	0.69675	2.652	0.90054	0.655	0.94253	CGC	SPTBN1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000258117.1	211.921207	KEEP		+	212.440457	0.441989	80	101	---	---	---	---	1	0.9999997	17	19	0	229	88	116	0	229	2	0	0	0	0	0	0	88	116	0	229	2	TP
IDH1	3417	broad.mit.edu	37	2	209113112	209113112	+	Missense_Mutation	SNP	C	C	T	rs121913500		GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr2:209113112C>T	ENST00000415913.1	-	4	776	c.395G>A	c.(394-396)cGt>cAt	p.R132H	IDH1_ENST00000446179.1_Missense_Mutation_p.R132H|IDH1_ENST00000345146.2_Missense_Mutation_p.R132H			O75874	IDHC_HUMAN	isocitrate dehydrogenase 1 (NADP+), soluble	132		NA	R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).	NA	2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle	cytosol|peroxisomal matrix	isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity	p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1)	NA	NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1)	4887				Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136)		ATAAGCATGACGACCTATGAT	0.393		NA	Mis		gliobastoma									NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(158;264 1958 3300 35450 36047)		Dom	yes		2	2q33.3	3417	"""isocitrate dehydrogenase 1 (NADP+), soluble"""		O	2835	Substitution - Missense(2834)|Complex - compound substitution(1)	central_nervous_system(2579)|haematopoietic_and_lymphoid_tissue(205)|bone(43)|prostate(4)|biliary_tract(2)|urinary_tract(1)|skin(1)					NA						79	73	75			NA	NA	2		NA															209113112		2203	4300	6503	SO:0001583	missense			ENSG00000138413	HGNC:5382		Approved	uc002vcu.3	NA	Q7Z3V0|Q93090|Q9NTJ9|Q9UKW8	ENST00000415913.1	37	CCDS2381.1	.	.	.	.	.	.	.	.	.	.	C	25.6	4.657324	0.88154	.	.	ENSG00000138413	ENST00000345146;ENST00000446179;ENST00000415913;ENST00000415282	D;D;D;D	0.86956	-2.19;-2.19;-2.19;-2.19	5.57	4.69	0.59074	Isopropylmalate dehydrogenase-like domain (2);	0.000000	0.85682	D	0.000000	D	0.93145	0.7817	H	0.99379	4.54	0.80722	D	1	B	0.25486	0.127	B	0.25405	0.06	D	0.92324	0.5868	10	0.87932	D	0	-20.0399	14.3783	0.66895	0.0:0.9288:0.0:0.0712	.	132	O75874	IDHC_HUMAN	H	132	ENSP00000260985:R132H;ENSP00000410513:R132H;ENSP00000390265:R132H;ENSP00000391075:R132H	ENSP00000260985:R132H	R	-	2	0	IDH1	208821357	1	0.71417	0.997	0.53966	0.992	0.81027	6.088	0.71371	1.356	0.45884	0.555	0.69702	CGT	IDH1-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336672.1	125.806899	KEEP		-	126.557221	0.409524	43	62	---	---	---	---	1	1	50	94	0	172	47	72	0	172	2	1	0.9427954	7	3	0	12	47	72	0	172	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178936091	178936091	+	Missense_Mutation	SNP	G	G	A	rs104886003		GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr3:178936091G>A	ENST00000263967.3	+	10	1790	c.1633G>A	c.(1633-1635)Gag>Aag	p.E545K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	545	PI3K helical.	NA	E -> A (in cancer).|E -> G (in KERSEB).|E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation; enhances invadopodia-mediated extracellular matrix degradation and invasion in breast cancer cells).	NA	epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E545K(881)|p.E545Q(18)	NA	NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAATCACTGAGCAGGAGAA	0.353	E545K(BC3C_URINARY_TRACT)|E545K(BFTC909_KIDNEY)|E545K(DLD1_LARGE_INTESTINE)|E545K(ESS1_ENDOMETRIUM)|E545K(HCC202_BREAST)|E545K(HCT15_LARGE_INTESTINE)|E545K(HSC4_UPPER_AERODIGESTIVE_TRACT)|E545K(HT1197_URINARY_TRACT)|E545K(HUH28_BILIARY_TRACT)|E545K(KYSE510_OESOPHAGUS)|E545K(L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|E545K(MCF7_BREAST)|E545K(MDAMB361_BREAST)|E545K(MKN1_STOMACH)|E545K(NCIH460_LUNG)|E545K(NCIH508_LARGE_INTESTINE)|E545K(NCIH596_LUNG)|E545K(RERFLCSQ1_LUNG)|E545K(TCCSUP_URINARY_TRACT)|E545K(TE5_OESOPHAGUS)	57	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	899	Substitution - Missense(899)	breast(308)|large_intestine(286)|urinary_tract(97)|lung(44)|endometrium(37)|ovary(25)|stomach(17)|upper_aerodigestive_tract(16)|skin(14)|central_nervous_system(13)|cervix(13)|thyroid(7)|oesophagus(7)|penis(4)|kidney(3)|soft_tissue(2)|pancreas(2)|haematopoietic_and_lymphoid_tissue(1)|biliary_tract(1)|NS(1)|pituitary(1)					NA						61	60	60			NA	NA	3		NA															178936091		1813	4072	5885	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	36	5.703347	0.96812	.	.	ENSG00000121879	ENST00000263967	T	0.63255	-0.03	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.73822	0.3636	L	0.51914	1.62	0.80722	D	1	D	0.62365	0.991	D	0.62955	0.909	T	0.68872	-0.5294	10	0.32370	T	0.25	-25.7963	20.0024	0.97423	0.0:0.0:1.0:0.0	.	545	P42336	PK3CA_HUMAN	K	545	ENSP00000263967:E545K	ENSP00000263967:E545K	E	+	1	0	PIK3CA	180418785	1	0.71417	1	0.80357	0.951	0.60555	9.476	0.97823	2.722	0.93159	0.467	0.42956	GAG	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	127.270153	KEEP		+	127.270153	0.5	41	41	---	---	---	---	1	0.9937572	5	7	0	110	48	51	0	110	2	1	1	67	78	0	150	48	51	0	110	2	TP
EIF4G1	1981	broad.mit.edu	37	3	184052651	184052651	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr3:184052651C>G	ENST00000342981.4	+	32	5172	c.4758C>G	c.(4756-4758)ttC>ttG	p.F1586L	FAM131A_ENST00000450976.1_5'Flank|FAM131A_ENST00000340957.5_5'Flank|EIF4G1_ENST00000427845.1_Missense_Mutation_p.F1499L|EIF4G1_ENST00000414031.1_Missense_Mutation_p.F1545L|EIF4G1_ENST00000352767.3_Missense_Mutation_p.F1592L|EIF4G1_ENST00000350481.5_Missense_Mutation_p.F1421L|EIF4G1_ENST00000411531.1_Missense_Mutation_p.F1546L|EIF2B5_ENST00000444495.1_Intron|EIF4G1_ENST00000382330.3_Missense_Mutation_p.F1592L|EIF4G1_ENST00000392537.2_Missense_Mutation_p.F1498L|EIF4G1_ENST00000346169.2_Missense_Mutation_p.F1585L|EIF4G1_ENST00000434061.2_Missense_Mutation_p.F1390L|EIF4G1_ENST00000424196.1_Missense_Mutation_p.F1592L|EIF4G1_ENST00000441154.1_Missense_Mutation_p.F1422L|FAM131A_ENST00000383847.2_5'Flank|EIF4G1_ENST00000319274.6_Missense_Mutation_p.F1585L|FAM131A_ENST00000418281.1_5'Flank|EIF4G1_ENST00000435046.2_Missense_Mutation_p.F1389L	NM_182917.4	NP_886553.3	Q04637	IF4G1_HUMAN	eukaryotic translation initiation factor 4 gamma, 1	1585	EIF4A-binding.|Necessary but not sufficient for MKNK1- binding.|W2.	NA		NA	insulin receptor signaling pathway|interspecies interaction between organisms|nuclear-transcribed mRNA poly(A) tail shortening|regulation of translational initiation	cytosol|eukaryotic translation initiation factor 4F complex	protein binding|translation initiation factor activity		NA	central_nervous_system(1)|cervix(2)|endometrium(3)|kidney(5)|large_intestine(14)|lung(41)|ovary(2)|prostate(1)|skin(5)|upper_aerodigestive_tract(1)	75	all_cancers(143;1.06e-10)|Ovarian(172;0.0339)		Epithelial(37;1.53e-33)|OV - Ovarian serous cystadenocarcinoma(80;2.72e-22)			TCACAGCCTTCTTCAAGTGGC	0.607		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						78	72	74			NA	NA	3		NA															184052651		2203	4300	6503	SO:0001583	missense			ENSG00000114867	HGNC:3296	NM_182917	Approved	uc010hxy.3	NA	D3DNT4|D3DNT5|O43177|O95066|Q5HYG0|Q6ZN21|Q8N102	ENST00000342981.4	37	CCDS54688.1	.	.	.	.	.	.	.	.	.	.	C	17.32	3.359408	0.61403	.	.	ENSG00000114867	ENST00000346169;ENST00000414031;ENST00000392537;ENST00000382330;ENST00000350481;ENST00000352767;ENST00000427845;ENST00000342981;ENST00000319274;ENST00000424196;ENST00000411531;ENST00000441154;ENST00000434061;ENST00000435046	D;D;D;D;D;D;D;D;D;D;D;D;D;D	0.86097	-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07;-2.07	4.38	3.5	0.40072	eIF4-gamma/eIF5/eIF2-epsilon (3);MIF4-like, type 1/2/3 (1);	0.000000	0.85682	D	0.000000	D	0.91212	0.7231	M	0.83603	2.65	0.58432	D	0.999999	D;D;D	0.76494	0.999;0.999;0.999	D;D;D	0.91635	0.999;0.999;0.994	D	0.90729	0.4641	10	0.72032	D	0.01	-3.0311	8.5328	0.33344	0.0:0.812:0.0:0.188	.	1592;1586;1585	E9PFM1;D3DNT2;Q04637	.;.;IF4G1_HUMAN	L	1585;1545;1498;1592;1421;1592;1499;1586;1585;1592;1546;1422;1390;1389	ENSP00000316879:F1585L;ENSP00000391935:F1545L;ENSP00000376320:F1498L;ENSP00000371767:F1592L;ENSP00000317600:F1421L;ENSP00000338020:F1592L;ENSP00000407682:F1499L;ENSP00000343450:F1586L;ENSP00000323737:F1585L;ENSP00000416255:F1592L;ENSP00000395974:F1546L;ENSP00000399858:F1422L;ENSP00000411826:F1390L;ENSP00000404754:F1389L	ENSP00000323737:F1585L	F	+	3	2	EIF4G1	185535345	1	0.71417	0.997	0.53966	0.397	0.30659	2.032	0.41127	1.061	0.40601	0.555	0.69702	TTC	EIF4G1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000345727.1	158.064462	KEEP		+	158.421406	0.436893	45	58	---	---	---	---	1	1	65	74	0	132	50	63	0	132	2	0	0	0	0	0	0	50	63	0	132	2	TP
POLR2B	5431	broad.mit.edu	37	4	57890238	57890238	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr4:57890238G>A	ENST00000381227.1	+	22	3337	c.2924G>A	c.(2923-2925)cGt>cAt	p.R975H	POLR2B_ENST00000314595.5_Missense_Mutation_p.R975H|POLR2B_ENST00000431623.2_Missense_Mutation_p.R900H|POLR2B_ENST00000441246.2_Missense_Mutation_p.R968H			P30876	RPB2_HUMAN	polymerase (RNA) II (DNA directed) polypeptide B, 140kDa	975		NA		NA	mRNA capping|nuclear mRNA splicing, via spliceosome|positive regulation of viral transcription|protein phosphorylation|transcription elongation from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|transcription-coupled nucleotide-excision repair|viral reproduction	DNA-directed RNA polymerase II, core complex	DNA binding|DNA-directed RNA polymerase activity|metal ion binding|protein binding|ribonucleoside binding		NA	breast(1)|central_nervous_system(2)|endometrium(6)|kidney(10)|large_intestine(9)|lung(17)|ovary(2)|prostate(4)|skin(1)	52	Glioma(25;0.08)|all_neural(26;0.181)					ATCCCCTCTCGTATGACTATT	0.378		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						134	123	127			NA	NA	4		NA															57890238		2203	4300	6503	SO:0001583	missense			ENSG00000047315	HGNC:9188	NM_000938	Approved	uc003hcl.1	NA	A8K1A8|Q8IZ61	ENST00000381227.1	37	CCDS3511.1	.	.	.	.	.	.	.	.	.	.	G	36	5.687573	0.96784	.	.	ENSG00000047315	ENST00000381227;ENST00000431623;ENST00000441246;ENST00000314595	D;D;D;D	0.98914	-5.23;-5.23;-5.23;-5.23	6.02	6.02	0.97574	DNA-directed RNA polymerase, subunit 2, domain 6 (2);	0.000000	0.85682	D	0.000000	D	0.99670	0.9877	H	0.99806	4.795	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.97110	1.0;1.0	D	0.97195	0.9860	10	0.87932	D	0	.	20.5373	0.99239	0.0:0.0:1.0:0.0	.	900;975	C9J4M6;P30876	.;RPB2_HUMAN	H	975;900;968;975	ENSP00000370625:R975H;ENSP00000391096:R900H;ENSP00000391452:R968H;ENSP00000312735:R975H	ENSP00000312735:R975H	R	+	2	0	POLR2B	57584995	1	0.71417	0.997	0.53966	0.989	0.77384	9.855	0.99526	2.857	0.98124	0.65	0.86243	CGT	POLR2B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250692.1	536.859784	KEEP		+	540.050635	0.615385	168	105	---	---	---	---	1	1	199	105	0	257	201	125	0	257	2	0	0	0	0	0	0	201	125	0	257	2	TP
LARS	51520	broad.mit.edu	37	5	145562190	145562190	+	5'UTR	SNP	G	G	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr5:145562190G>A	ENST00000394434.2	-	0	33				LARS_ENST00000510191.1_5'Flank|LARS_ENST00000511505.1_5'UTR|LARS_ENST00000274562.9_5'Flank|LARS_ENST00000545646.1_5'Flank	NM_020117.9	NP_064502.9	Q9P2J5	SYLC_HUMAN	leucyl-tRNA synthetase	NA		NA		NA	leucyl-tRNA aminoacylation	cytosol	ATP binding|leucine-tRNA ligase activity|protein binding		NA	breast(2)|cervix(1)|endometrium(2)|kidney(2)|large_intestine(6)|lung(10)|prostate(1)|skin(2)|stomach(8)	34			KIRC - Kidney renal clear cell carcinoma(527;0.000785)|Kidney(363;0.00101)		L-Leucine(DB00149)	CACACCTGCTGAGGCAATCAT	0.587		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA			NA	NA			NA															NA		NA	NA	NA	SO:0001623	5_prime_UTR_variant			ENSG00000133706	HGNC:6512	NM_020117	Approved	uc003lnx.1	NA	A7E266|Q9NSE1	ENST00000394434.2	37	CCDS34265.1												NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		LARS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000373367.1	67.186319	KEEP		-	69.101358	0.777778	21	6	---	---	---	---	1	0.9997501	4	6	0	35	21	6	0	35	2	0	0	0	0	0	0	21	6	0	35	2	TP
VARS2	57176	broad.mit.edu	37	6	30893483	30893483	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr6:30893483A>G	ENST00000321897.5	+	27	3580	c.2948A>G	c.(2947-2949)tAc>tGc	p.Y983C	VARS2_ENST00000541562.1_Missense_Mutation_p.Y1013C|VARS2_ENST00000476162.1_3'UTR|VARS2_ENST00000542001.1_Missense_Mutation_p.Y843C|VARS2_ENST00000416670.2_Missense_Mutation_p.Y983C			Q5ST30	SYVM_HUMAN	valyl-tRNA synthetase 2, mitochondrial	983		NA		NA	valyl-tRNA aminoacylation	mitochondrion	ATP binding|valine-tRNA ligase activity		NA	central_nervous_system(2)|cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(9)|lung(15)|ovary(3)|prostate(3)|skin(4)|urinary_tract(1)	46						GCTCAAGTCTACATGGAGCTG	0.647		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						14	17	16			NA	NA	6		NA															30893483		1503	2701	4204	SO:0001583	missense			ENSG00000137411	HGNC:21642	NM_020442	Approved	uc011dmz.2	NA	A2ABL7|Q2M2A0|Q59FI1|Q5SQ96|Q5SS98|Q6DKJ5|Q6ZV24|Q96GN2|Q96H77|Q96Q02|Q9H6R2|Q9UFH7	ENST00000321897.5	37	CCDS34387.1	.	.	.	.	.	.	.	.	.	.	A	15.45	2.838219	0.51057	.	.	ENSG00000137411	ENST00000321897;ENST00000416670;ENST00000542001;ENST00000541562	T;T;T;T	0.36520	1.25;1.25;1.25;1.25	5.74	3.07	0.35406	Aminoacyl-tRNA synthetase, class 1a, anticodon-binding (1);	0.460281	0.23014	N	0.052928	T	0.32556	0.0833	M	0.68317	2.08	0.30892	N	0.730245	D;P;D;D	0.67145	0.996;0.953;0.973;0.972	P;B;P;P	0.56216	0.794;0.315;0.724;0.75	T	0.13045	-1.0524	10	0.54805	T	0.06	-13.3864	8.1342	0.31046	0.6523:0.0:0.0:0.3477	.	421;981;1013;983	Q5ST30-2;B7ZL25;F5GXJ0;Q5ST30	.;.;.;SYVM_HUMAN	C	983;983;843;1013	ENSP00000316092:Y983C;ENSP00000394802:Y983C;ENSP00000438200:Y843C;ENSP00000441000:Y1013C	ENSP00000316092:Y983C	Y	+	2	0	VARS2	31001462	0.88	0.30214	0.993	0.49108	0.982	0.71751	0.889	0.28282	0.916	0.36871	0.533	0.6212	TAC	VARS2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076566.2	67.251175	KEEP		+	67.273793	0.473684	18	20	---	---	---	---	1	0.9936473	6	8	0	45	20	24	0	45	2	0	0	0	0	0	0	20	24	0	45	2	TP
LMBRD1	55788	broad.mit.edu	37	6	70411840	70411840	+	Silent	SNP	G	G	C			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr6:70411840G>C	ENST00000370577.3	-	10	1150	c.921C>G	c.(919-921)gtC>gtG	p.V307V	LMBRD1_ENST00000370570.1_Silent_p.V234V	NM_018368.3	NP_060838.3	Q9NUN5	LMBD1_HUMAN	LMBR1 domain containing 1	307		NA		NA	interspecies interaction between organisms|transport	integral to membrane|lysosomal membrane	cobalamin binding		NA	breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(4)|large_intestine(7)|lung(11)|ovary(2)|upper_aerodigestive_tract(1)	31						ATATTCCCCAGACGATCTAAA	0.269		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						50	51	50			NA	NA	6		NA															70411840		2200	4286	6486	SO:0001819	synonymous_variant			ENSG00000168216	HGNC:23038	NM_018368	Approved	uc003pfa.3	NA	A8K204|E1P531|Q5VUN6|Q86Y70|Q96FW4|Q9BY56|Q9NZD6	ENST00000370577.3	37	CCDS4969.1												NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		LMBRD1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041124.1	171.067309	KEEP		-	171.245242	0.454545	45	54	---	---	---	---	1	1	40	46	0	86	50	61	0	86	2	0	0	0	0	0	0	50	61	0	86	2	TP
Unknown	0	broad.mit.edu	37	7	72307268	72307268	+	IGR	SNP	T	T	C			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr7:72307268T>C			NA	NA				TYW1B (8515 upstream) : RN7SL625P (4748 downstream)						NA		NA		NA					NA		NA						AAGAAGGAGATGAGAAATTTG	0.398		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA			NA	NA			NA															NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37													NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						0			146.609665	KEEP			147.095148	0.425743	43	58	---	---	---	---	1	1	29	28	0	145	48	68	0	145	2	0	0	0	0	0	0	48	68	0	145	2	TP
TUT1	64852	broad.mit.edu	37	11	62343579	62343579	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr11:62343579G>A	ENST00000476907.1	-	9	2303	c.1612C>T	c.(1612-1614)Ccc>Tcc	p.P538S	EEF1G_ENST00000378019.3_5'Flank|TUT1_ENST00000308436.7_Missense_Mutation_p.P576S|EEF1G_ENST00000329251.4_5'Flank|MIR3654_ENST00000496634.2_Intron|EEF1G_ENST00000532986.1_5'Flank			Q9H6E5	STPAP_HUMAN	terminal uridylyl transferase 1, U6 snRNA-specific	538	PAP-associated.	NA		NA	mRNA cleavage|mRNA polyadenylation|snRNA processing	nuclear speck|nucleolus	ATP binding|enzyme binding|mRNA 3'-UTR binding|polynucleotide adenylyltransferase activity|RNA uridylyltransferase activity|zinc ion binding		NA	breast(1)|central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(3)|lung(15)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	29						AGATTCAGGGGGCCAAGGCGC	0.637		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						23	26	25			NA	NA	11		NA															62343579		2198	4291	6489	SO:0001583	missense			ENSG00000149016	HGNC:26184	NM_022830	Approved	uc001nto.2	NA	A1A527|A8K995|Q2NL65|Q7L583|Q9H6H7	ENST00000476907.1	37		.	.	.	.	.	.	.	.	.	.	G	18.58	3.654502	0.67472	.	.	ENSG00000149016	ENST00000308436;ENST00000476907	T;T	0.55413	0.52;0.52	5.39	4.48	0.54585	PAP/25A-associated (1);	0.115106	0.64402	N	0.000012	T	0.59252	0.2180	L	0.34521	1.04	0.44366	D	0.997264	D;D	0.55172	0.97;0.963	D;P	0.65684	0.937;0.852	T	0.61182	-0.7114	10	0.59425	D	0.04	-18.5405	11.8888	0.52618	0.0849:0.0:0.9151:0.0	.	538;576	Q9H6E5;F5H0R1	STPAP_HUMAN;.	S	576;538	ENSP00000308000:P576S;ENSP00000419607:P538S	ENSP00000308000:P576S	P	-	1	0	TUT1	62100155	1	0.71417	1	0.80357	0.836	0.474	5.269	0.65542	1.282	0.44496	-0.253	0.11424	CCC	TUT1-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000351319.2	69.60761	KEEP		-	70.721851	0.359375	23	41	---	---	---	---	1	0.9903442	6	12	0	67	23	44	0	67	2	0	0	0	0	0	0	23	44	0	67	2	TP
BUD13	84811	broad.mit.edu	37	11	116627935	116627935	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr11:116627935G>A	ENST00000260210.4	-	9	1716	c.1693C>T	c.(1693-1695)Cgc>Tgc	p.R565C	BUD13_ENST00000375445.3_Missense_Mutation_p.R431C	NM_032725.3	NP_116114.1	Q9BRD0	BUD13_HUMAN	BUD13 homolog (S. cerevisiae)	565		NA		NA					NA	endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(11)|pancreas(2)|skin(1)|urinary_tract(1)	22	all_hematologic(175;0.0487)	all_cancers(61;1.72e-06)|all_epithelial(67;0.000735)|Melanoma(852;0.022)|Acute lymphoblastic leukemia(157;0.0255)|Medulloblastoma(222;0.0523)|Breast(348;0.056)|all_hematologic(158;0.0588)		BRCA - Breast invasive adenocarcinoma(274;1.49e-06)|Epithelial(105;5.81e-06)|all cancers(92;0.000144)|OV - Ovarian serous cystadenocarcinoma(223;0.154)		CCACTGTAGCGAGGTCTCACT	0.413		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						72	70	71			NA	NA	11		NA															116627935		2201	4296	6497	SO:0001583	missense			ENSG00000137656	HGNC:28199	NM_032725	Approved	uc001ppn.3	NA	A8K0S0|Q96LS7	ENST00000260210.4	37	CCDS8374.1	.	.	.	.	.	.	.	.	.	.	G	14.28	2.487326	0.44249	.	.	ENSG00000137656	ENST00000375445;ENST00000260210	T;T	0.20332	2.13;2.08	6.04	6.04	0.98038	.	0.048954	0.85682	D	0.000000	T	0.23410	0.0566	L	0.51914	1.62	0.80722	D	1	B;B	0.22851	0.03;0.076	B;B	0.25506	0.018;0.061	T	0.01753	-1.1281	10	0.87932	D	0	-9.1507	13.4467	0.61144	0.0:0.0:0.7438:0.2562	.	431;565	Q9BRD0-2;Q9BRD0	.;BUD13_HUMAN	C	431;565	ENSP00000364594:R431C;ENSP00000260210:R565C	ENSP00000260210:R565C	R	-	1	0	BUD13	116133145	1	0.71417	1	0.80357	0.96	0.62799	1.875	0.39578	2.873	0.98535	0.643	0.83706	CGC	BUD13-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000104864.1	94.414877	KEEP		-	94.614145	0.442857	31	39	---	---	---	---	1	0.9999572	12	16	0	94	32	44	0	94	2	0	0	0	0	0	0	32	44	0	94	2	TP
METTL1	4234	broad.mit.edu	37	12	58162739	58162739	+	3'UTR	SNP	A	A	G	rs703842	by1000genomes	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr12:58162739A>G	ENST00000324871.7	-	0	1580				METTL21B_ENST00000548256.1_5'Flank|CYP27B1_ENST00000546496.1_5'Flank|METTL1_ENST00000548681.1_5'Flank|CYP27B1_ENST00000228606.4_5'Flank|RP11-571M6.13_ENST00000546609.1_RNA|METTL1_ENST00000257848.7_3'UTR	NM_005371.5	NP_005362.3	Q9UBP6	TRMB_HUMAN	methyltransferase like 1	NA		NA		NA		cytoplasm|nucleus	protein binding|tRNA (guanine-N7-)-methyltransferase activity|tRNA binding		NA	large_intestine(1)|lung(2)|upper_aerodigestive_tract(1)	4	all_cancers(7;6.73e-81)|Lung NSC(6;1.07e-25)|all_lung(6;8.25e-24)|all_epithelial(6;4.6e-17)|Glioma(12;6.95e-05)|all_neural(12;0.00016)|Melanoma(17;0.122)		BRCA - Breast invasive adenocarcinoma(9;0.211)			CTTTTCTCTAATCCCTGGGAG	0.547		NA											G	914	0.42	0.35	0.28	2184	0.69	0.9997	,	,	NA	3e-04	0.33	NA	NA	0.4186	0.9994	LOWCOV,EXOME	NA	NA	7e-04	SNP								NA				0							NA	G	,	1380,3026	686.3+/-404.7	212,956,1035	45	46	46	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	,	1.6	0	12	dbSNP_86	46	2770,5830	676.2+/-403.3	457,1856,1987	yes	utr-3,utr-3	METTL1	NM_005371.5,NM_023033.3	,	669,2812,3022	GG,GA,AA	http://www.ncbi.nlm.nih.gov/pubmed?term	32.2093,31.3209,31.9083	,	,	58162739	4150,8856	2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000037897	HGNC:7030	NM_005371	Approved	uc010ssd.2	NA	B2RBX1|Q14105	ENST00000324871.7	37	CCDS8955.3												NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		METTL1-001	KNOWN	upstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000316528.3	-15.834541	KEEP		-	12.390223	0.040323	5	119	---	---	---	---	1	0.2720935	2	22	0	103	5	134	0	103	2	0	0	0	0	0	0	5	134	0	103	2	TP
LACTB	114294	broad.mit.edu	37	15	63433763	63433763	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr15:63433763A>G	ENST00000261893.4	+	6	1475	c.1403A>G	c.(1402-1404)gAa>gGa	p.E468G	RPS27L_ENST00000559763.1_Intron	NM_032857.3	NP_116246.2	P83111	LACTB_HUMAN	lactamase, beta	468		NA		NA		mitochondrion	hydrolase activity		NA	NS(1)|breast(1)|kidney(1)|large_intestine(3)|lung(3)|prostate(1)|skin(1)|stomach(1)	12						GGTGTTGTGGAAAGGAAACAA	0.483		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(85;443 1381 6215 27308 35583)							NA				0							NA						78	68	71			NA	NA	15		NA															63433763		2203	4300	6503	SO:0001583	missense			ENSG00000103642	HGNC:16468	NM_032857	Approved	uc002alw.3	NA	P83096	ENST00000261893.4	37	CCDS10182.1	.	.	.	.	.	.	.	.	.	.	A	17.01	3.280394	0.59758	.	.	ENSG00000103642	ENST00000261893	T	0.41065	1.01	5.64	5.64	0.86602	Beta-lactamase/transpeptidase-like (2);Beta-lactamase-related (1);	0.000000	0.85682	D	0.000000	T	0.55242	0.1908	L	0.54323	1.7	0.80722	D	1	D	0.54397	0.966	P	0.58013	0.831	T	0.54616	-0.8267	10	0.48119	T	0.1	-25.3143	15.3269	0.74172	1.0:0.0:0.0:0.0	.	468	P83111	LACTB_HUMAN	G	468	ENSP00000261893:E468G	ENSP00000261893:E468G	E	+	2	0	LACTB	61220816	1	0.71417	0.999	0.59377	0.652	0.38707	8.99	0.9351	2.273	0.75805	0.46	0.3903	GAA	LACTB-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256224.1	175.656825	KEEP		+	175.788331	0.462264	49	57	---	---	---	---	1	0.9753652	2	8	0	153	54	64	0	153	2	0	0	0	0	0	0	54	64	0	153	2	TP
TP53	7157	broad.mit.edu	37	17	7577517	7577517	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr17:7577517A>C	ENST00000420246.2	-	7	896	c.764T>G	c.(763-765)aTc>aGc	p.I255S	TP53_ENST00000574684.1_5'Flank|TP53_ENST00000269305.4_Missense_Mutation_p.I255S|TP53_ENST00000445888.2_Missense_Mutation_p.I255S|TP53_ENST00000359597.4_Missense_Mutation_p.I255S|TP53_ENST00000413465.2_Missense_Mutation_p.I255S|TP53_ENST00000455263.2_Missense_Mutation_p.I255S	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	255	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).	NA	I -> F (in sporadic cancers; somatic mutation).|I -> M (in sporadic cancers; somatic mutation).|I -> N (in sporadic cancers; somatic mutation).|I -> S (in sporadic cancers; somatic mutation).|I -> T (in sporadic cancers; somatic mutation).|I -> V (in sporadic cancers; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.I255S(10)|p.0?(8)|p.I255T(7)|p.I255del(7)|p.I255N(7)|p.I255fs*8(1)|p.?(1)|p.I254fs*7(1)|p.I254_T256del(1)|p.R249_T256delRPILTIIT(1)	NA	NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		TTCCAGTGTGATGATGGTGAG	0.582		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	44	Substitution - Missense(24)|Deletion - In frame(9)|Whole gene deletion(8)|Deletion - Frameshift(2)|Unknown(1)	breast(10)|pancreas(6)|ovary(4)|bone(4)|upper_aerodigestive_tract(3)|large_intestine(2)|central_nervous_system(2)|haematopoietic_and_lymphoid_tissue(2)|urinary_tract(2)|oesophagus(2)|lung(2)|thyroid(1)|stomach(1)|liver(1)|endometrium(1)|skin(1)					NA						145	104	118			NA	NA	17		NA															7577517		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	A	16.91	3.251627	0.59212	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000509690	D;D;D;D;D;D;D	0.99814	-6.89;-6.89;-6.89;-6.89;-6.89;-6.89;-6.89	4.62	4.62	0.57501	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.058771	0.64402	D	0.000004	D	0.99654	0.9872	M	0.73962	2.25	0.58432	D	0.999999	D;D;D;D;D	0.89917	1.0;0.994;0.999;1.0;1.0	D;P;D;D;D	0.87578	0.996;0.901;0.996;0.998;0.998	D	0.97461	1.0034	10	0.87932	D	0	-21.9257	12.3101	0.54924	1.0:0.0:0.0:0.0	.	255;255;255;255;255	P04637-2;P04637-3;P04637;Q1MSW8;E7EQX7	.;.;P53_HUMAN;.;.	S	255;255;255;255;255;255;244;123	ENSP00000410739:I255S;ENSP00000352610:I255S;ENSP00000269305:I255S;ENSP00000398846:I255S;ENSP00000391127:I255S;ENSP00000391478:I255S;ENSP00000425104:I123S	ENSP00000269305:I255S	I	-	2	0	TP53	7518242	1	0.71417	0.998	0.56505	0.393	0.30537	9.087	0.9411	2.074	0.6221	0.379	0.24179	ATC	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	135.239207	KEEP		-	135.443079	0.558824	38	30	---	---	---	---	1	1	26	10	0	83	44	31	0	83	2	1	1	260	267	0	680	44	31	0	83	2	TP
TP53	7157	broad.mit.edu	37	17	7578263	7578263	+	Nonsense_Mutation	SNP	G	G	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr17:7578263G>A	ENST00000420246.2	-	6	718	c.586C>T	c.(586-588)Cga>Tga	p.R196*	TP53_ENST00000574684.1_Intron|TP53_ENST00000269305.4_Nonsense_Mutation_p.R196*|TP53_ENST00000445888.2_Nonsense_Mutation_p.R196*|TP53_ENST00000359597.4_Nonsense_Mutation_p.R196*|TP53_ENST00000413465.2_Nonsense_Mutation_p.R196*|TP53_ENST00000455263.2_Nonsense_Mutation_p.R196*	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	196	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> Q (in sporadic cancers; somatic mutation).|R -> S (in a sporadic cancer; somatic mutation).	NA	activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R196*(167)|p.R64*(14)|p.R103*(14)|p.0?(8)|p.R196fs*51(7)|p.?(5)|p.A189_V197delAPPQHLIRV(4)|p.P191_E198>Q(3)|p.R196R(2)|p.I195fs*50(1)|p.R64fs*>27(1)|p.R103fs*51(1)|p.P191fs*6(1)|p.I195_G199delIRVEG(1)|p.P98_E105>Q(1)|p.I195fs*12(1)|p.P59_E66>Q(1)	NA	NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		CCTTCCACTCGGATAAGATGC	0.552		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	232	Substitution - Nonsense(195)|Deletion - Frameshift(11)|Whole gene deletion(8)|Deletion - In frame(5)|Complex - deletion inframe(5)|Unknown(5)|Substitution - coding silent(2)|Complex - frameshift(1)	large_intestine(54)|breast(29)|upper_aerodigestive_tract(22)|lung(22)|haematopoietic_and_lymphoid_tissue(17)|skin(17)|biliary_tract(11)|central_nervous_system(11)|oesophagus(11)|ovary(11)|stomach(8)|urinary_tract(7)|bone(4)|liver(3)|pancreas(3)|eye(1)|kidney(1)	GRCh37	CM941329	TP53	M	NA						102	91	94			NA	NA	17		NA															7578263		2203	4300	6503	SO:0001587	stop_gained	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	14.02	2.409843	0.42715	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	.	.	.	5.41	4.44	0.5379	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-19.9531	12.3046	0.54895	0.0827:0.0:0.9173:0.0	.	.	.	.	X	196;196;196;196;196;196;185;103;64;103;64	.	ENSP00000269305:R196X	R	-	1	2	TP53	7518988	1	0.71417	0.997	0.53966	0.023	0.10783	2.166	0.42406	1.427	0.47276	-0.14	0.14226	CGA	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	144.007126	KEEP		-	144.18123	0.55	44	36	---	---	---	---	0	0.9999681	1	23	1	96	47	41	1	96	3	1	1	243	352	0	584	47	41	1	96	2	TP
POLDIP2	26073	broad.mit.edu	37	17	26675209	26675209	+	Silent	SNP	C	C	A			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chr17:26675209C>A	ENST00000540200.1	-	12	1037	c.1038G>T	c.(1036-1038)cgG>cgT	p.R346R	POLDIP2_ENST00000003607.4_5'UTR	NM_015584.3	NP_056399.1	Q9Y2S7	PDIP2_HUMAN	polymerase (DNA-directed), delta interacting protein 2	347	ApaG.	NA		NA		mitochondrial nucleoid|nucleus			NA		NA	all_lung(13;0.000354)|Lung NSC(42;0.00115)			UCEC - Uterine corpus endometrioid carcinoma (53;0.154)		AGGGAGGAATCCGAACATCAA	0.547		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						103	104	104			NA	NA	17		NA															26675209		1899	4124	6023	SO:0001819	synonymous_variant			ENSG00000004142	HGNC:23781	NM_015584	Approved	uc002haz.3	NA	B2R846|Q96JE4	ENST00000540200.1	37													NA	NA	NA								NA	NA	NA												NA		NA															NA	NA												NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		POLDIP2-201	KNOWN	basic	protein_coding	NA	protein_coding		69.760451	KEEP		-	70.347532	0.396825	25	38	---	---	---	---	1	1	57	80	0	117	30	50	0	117	2	0	0	0	0	0	0	30	50	0	117	2	TP
CXorf22	170063	broad.mit.edu	37	X	35985840	35985840	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chrX:35985840C>T	ENST00000297866.5	+	10	1771	c.1705C>T	c.(1705-1707)Cgc>Tgc	p.R569C		NM_152632.3	NP_689845.2	Q6ZTR5	CX022_HUMAN	chromosome X open reading frame 22	569		NA		NA					NA	breast(2)|central_nervous_system(2)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(9)|lung(18)|ovary(1)|pancreas(1)|upper_aerodigestive_tract(3)	44						AGCCATGACACGCACTCACAA	0.453		NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						128	98	108			NA	NA	X		NA															35985840		2202	4300	6502	SO:0001583	missense			ENSG00000165164	HGNC:28546	NM_152632	Approved	uc004ddj.3	NA	Q5JRM8|Q8N6X8	ENST00000297866.5	37	CCDS14237.2	.	.	.	.	.	.	.	.	.	.	C	10.12	1.264365	0.23136	.	.	ENSG00000165164	ENST00000297866	T	0.14893	2.47	5.35	-10.5	0.00291	.	3.690700	0.00754	N	0.001095	T	0.07279	0.0184	N	0.16478	0.41	0.0931	N	1	B	0.13145	0.007	B	0.10450	0.005	T	0.22417	-1.0217	10	0.42905	T	0.14	-29.6035	0.1415	0.00084	0.339:0.2048:0.1732:0.283	.	569	Q6ZTR5	CX022_HUMAN	C	569	ENSP00000297866:R569C	ENSP00000297866:R569C	R	+	1	0	CXorf22	35895761	0	0.05858	0	0.03702	0	0.00434	-1.969	0.01506	-2.074	0.00877	-1.449	0.01048	CGC	CXorf22-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056216.2	44.544368	KEEP		+	48.059556	0.257576	17	49	---	---	---	---	0	0	0	0	0	103	22	53	0	103	2	1	0.9999999	46	139	1	207	22	53	0	103	10	TP
ATRX	546	broad.mit.edu	37	X	76778818	76778818	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-5417-Tumor-SM-1QETV	GBM-TCGA-06-5417-Normal-SM-1QEUR	g.chrX:76778818T>C	ENST00000373344.5	-	31	6975	c.6761A>G	c.(6760-6762)cAt>cGt	p.H2254R	ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Missense_Mutation_p.H2216R	NM_000489.3	NP_000480.2	P46100	ATRX_HUMAN	alpha thalassemia/mental retardation syndrome X-linked	2254		NA		NA	DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent	nuclear heterochromatin	ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding	p.H2254R(1)	NA	bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	145					Phosphatidylserine(DB00144)	AAGAGAATCATGTTCATGGTA	0.388		NA	"""Mis, F, N"""		"""Pancreatic neuroendocrine tumors, paediatric GBM"""		ATR-X (alpha thalassemia/mental retardation) syndrome							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		X	Xq21.1	546	alpha thalassemia/mental retardation syndrome X-linked	yes	E	1	Substitution - Missense(1)	central_nervous_system(1)					NA						232	194	207			NA	NA	X		NA															76778818		2203	4296	6499	SO:0001583	missense			ENSG00000085224	HGNC:886	NM_000489	Approved	uc004ecp.4	NA	D3DTE2|P51068|Q15886|Q59FB5|Q59H31|Q5H9A2|Q5JWI4|Q7Z2J1|Q9H0Z1|Q9NTS3	ENST00000373344.5	37	CCDS14434.1	.	.	.	.	.	.	.	.	.	.	T	14.17	2.456434	0.43634	.	.	ENSG00000085224	ENST00000373344;ENST00000395603	D;D	0.95412	-3.7;-3.7	5.35	5.35	0.76521	.	0.000000	0.85682	U	0.000000	D	0.97455	0.9167	M	0.77486	2.375	0.80722	D	1	D;D	0.89917	1.0;0.999	D;D	0.85130	0.997;0.991	D	0.98141	1.0436	10	0.87932	D	0	-10.035	14.4136	0.67135	0.0:0.0:0.0:1.0	.	2216;2254	P46100-4;P46100	.;ATRX_HUMAN	R	2254;2216	ENSP00000362441:H2254R;ENSP00000378967:H2216R	ENSP00000362441:H2254R	H	-	2	0	ATRX	76665474	1	0.71417	1	0.80357	0.992	0.81027	7.694	0.84235	1.784	0.52394	0.437	0.2879	CAT	ATRX-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000058860.2	608.811565	KEEP		-	609.081285	0.529577	188	167	---	---	---	---	1	1	28	2	0	436	193	176	0	436	2	1	1	136	120	2	242	193	176	0	436	8	TP
